A detailed history of Moneco Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Moneco Advisors, LLC holds 6,353 shares of GILD stock, worth $572,977. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,353
Previous 6,266 1.39%
Holding current value
$572,977
Previous $429,000 24.01%
% of portfolio
0.07%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$66.59 - $83.99 $5,793 - $7,307
87 Added 1.39%
6,353 $532,000
Q2 2024

Jul 19, 2024

BUY
$63.15 - $72.88 $7,893 - $9,110
125 Added 2.04%
6,266 $429,000
Q1 2024

Apr 25, 2024

SELL
$71.58 - $87.29 $12,598 - $15,363
-176 Reduced 2.79%
6,141 $449,000
Q4 2023

Mar 13, 2024

BUY
$73.27 - $83.09 $50,629 - $57,415
691 Added 12.28%
6,317 $511,000
Q4 2023

Feb 05, 2024

BUY
$73.27 - $83.09 $50,409 - $57,165
688 Added 12.24%
6,307 $510,000
Q3 2023

Mar 13, 2024

BUY
$73.94 - $80.67 $41,258 - $45,013
558 Added 11.01%
5,626 $421,000
Q3 2023

Nov 03, 2023

BUY
$73.94 - $80.67 $41,036 - $44,771
555 Added 10.96%
5,619 $421,000
Q2 2023

Mar 13, 2024

SELL
$76.01 - $86.7 $94,176 - $107,421
-1,239 Reduced 19.64%
5,068 $390,000
Q2 2023

Aug 02, 2023

BUY
$76.01 - $86.7 $17,330 - $19,767
228 Added 4.71%
5,064 $390,000
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $64,399 - $73,370
833 Added 20.81%
4,836 $401,000
Q4 2022

Jan 27, 2023

BUY
$62.32 - $89.47 $15,704 - $22,546
252 Added 6.72%
4,003 $343,000
Q3 2022

Nov 01, 2022

BUY
$59.54 - $68.01 $223,334 - $255,105
3,751 New
3,751 $231,000
Q4 2021

Feb 08, 2022

SELL
$64.88 - $73.64 $192,953 - $219,005
-2,974 Closed
0 $0
Q3 2021

Nov 03, 2021

SELL
$67.69 - $73.03 $25,519 - $27,532
-377 Reduced 11.25%
2,974 $208,000
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $212,687 - $232,391
3,351 New
3,351 $231,000
Q3 2020

Oct 20, 2020

SELL
$62.1 - $78.08 $163,447 - $205,506
-2,632 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$72.34 - $84.0 $190,398 - $221,088
2,632 New
2,632 $203,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Moneco Advisors, LLC Portfolio

Follow Moneco Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneco Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneco Advisors, LLC with notifications on news.